The role of whole brain radiation in primary CNS lymphoma

Benjamin Kasenda, Jay Loeffler, Gerald Illerhaus, Andŕes J M Ferreri, James Rubenstein, Tracy T. Batchelor

Research output: Contribution to journalArticlepeer-review

Abstract

A 63-year-old woman presented with progressive dizziness and headaches. A brain magnetic resonance imaging (MRI) revealed a 3 3 4 cm contrast enhancing single mass in the right parietal lobe; stereotactic biopsy of themass revealed aCD20-positive diffuse large B-cell lymphoma (DLBCL). Body fluorodeoxyglucose-positron emission tomography scan and bone marrow biopsy were negative. The patient had no other health issues. She had good performance status when starting treatment with the combination of rituximab, high-dose methotrexate (HD-MTX) (3.5 g/m2), and high-dose cytarabine (HD-Ara-C) (2 3 2 g/m2). After 4 courses, she achieved a partial radiographic response. After 2 more courses, she achieved a complete radiographic response. After achieving complete response (CR), myeloablative, nonmyeloablative chemotherapy, or whole brain radiotherapy (WBRT) were considered as consolidative treatments to reduce the risk of relapse.

Original languageEnglish
Pages (from-to)32-36
Number of pages5
JournalBlood
Volume128
Issue number1
DOIs
Publication statusPublished - Jul 7 2016

ASJC Scopus subject areas

  • Hematology
  • Biochemistry
  • Cell Biology
  • Immunology

Fingerprint Dive into the research topics of 'The role of whole brain radiation in primary CNS lymphoma'. Together they form a unique fingerprint.

Cite this